JAK2 Mutation Test Kit

About Genefirst

GeneFirst is a private, commercial-stage molecular diagnostics company focused on developing and providing proprietary testing solutions. Its core technology platforms include ATOM-Seq (a next-generation sequencing capture chemistry for challenging samples), MMD (a high-sensitivity qPCR-based mutation detection assay), and MPA (a multiplex qPCR platform using high-resolution melt curve analysis). The company's marketed portfolio targets clear clinical needs in oncology (e.g., JAK2/ABL mutation kits), women's health (HPV DNA/RNA testing), and respiratory infections (multiplex pneumonia panels), positioning it as a specialized provider of fast, simple, and reliable molecular tests.

Therapeutic Areas